MD
MDGL
Madrigal Pharmaceuticals
$534.49
1M -0.3%
3M +12.7%
YTD -10.0%
as of 2026-09-11
✓Watchlist
↑↓ next ticker
· ⌘+↑↓ or scroll to zoom
· ←→ pan · 0 reset
▲ buy
▼ sell · size ≈ trade size
· ─ moving averages ·
click the buttons above to hide them
Model view — historical tendencies for the days ahead, not a forecast
Seasonality
Mildly negative window
Next 30 days (to Oct 14): -2.4% median,
50% of the last 18 years finished up.
20-year seasonality chart →
Mean reversion
Neutral — RSI(2) at 37
RSI(2) under 15 is oversold (this name has historically bounced); over 85 is overbought.
Its dip-buy edge in history is -0.26%/day.
Mean-reversion stats →
1-month breakdown —
Market · β 0.35 -0.1% · Seasonal tilt -0.1%
$118M/day volume
44% volatility
+24% 1-year
-13% from ATH
52-week range · 64% of the way up · -13% from the high
$393.61$615.00
Congressional trades in MDGL
Full tracker →
1 member · 0 buys / 1 sells
· $1K–$15K disclosed · latest filing May 19, 2023.
| SELL |
DG Daniel Goldman
· traded Apr 10, 2023 |
$1K–$15K |
Data from the U.S. House Clerk and FINRA, plus end-of-day prices. Not investment advice.